The Tradeoff Between the Risks of Acute Rejection and New-Onset Diabetes After Kidney Transplant  Christina L. Klein, MD, Daniel C. Brennan, MD, FACP  American Journal of Kidney Diseases  Volume 56, Issue 6, Pages 1026-1028 (December 2010) DOI: 10.1053/j.ajkd.2010.09.010 Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 (A) Hazard ratios for adjusted death-censored transplant failure after 1 year posttransplant. Acute rejection (AR) is associated significantly with higher risk. (B) Hazard ratios for adjusted all-cause and cardiovascular mortality. Pretransplant diabetes mellitus (PDM) is associated significantly with both all-cause and cardiovascular mortality, whereas AR is associated significantly with all-cause mortality alone. Reference group is no diabetes, no rejection. Error bars indicate 95% confidence interval. *P < 0.05. Abbreviation: NODAT, new-onset diabetes after transplant. American Journal of Kidney Diseases 2010 56, 1026-1028DOI: (10.1053/j.ajkd.2010.09.010) Copyright © 2010 National Kidney Foundation, Inc. Terms and Conditions